Helicobacter pylori and gastro-esophageal reflux disease (GERD)

Main Article Content

Murad Lesmana


Helicobacter pylori is the major cause of gastritis and duodenitis, and is responsible for the majority of gastric and duodenal ulcers. It is thought that H.pylori may have a benign influence in the prevention of reflux esophagitis and gastro-esophageal reflux disease (GERD). GERD is due to failure of the gastro-esophageal anti-reflux mechanism, thus allowing gastric acid to damage the esophageal mucosa, but the main abnormalities may also be found in the stomach and duodenum. The recently decreased prevalence of H.pylori has led to a lower incidence of duodenal ulcer and gastric carcinoma, but increasing acid secretion resulted in an increase in GERD. Eradication of H.pylori does not aggravate the symptoms of GERD and also does not induce the development of GERD in the normal population or in patients with duodenal ulcer. Pharmacological suppression of acid secretion is more effective in patients infected with H.pylori in comparison to non-infected individuals. The evidence on the efficacy of acid suppression therapy and its association with H.pylori infection is still contradictory. The sharply differing opinions regarding the role or association of H.pylori infection with GERD have not been reconciled and contradictory study results are still widespread.

Article Details

How to Cite
Lesmana, M. (2010). Helicobacter pylori and gastro-esophageal reflux disease (GERD). Universa Medicina, 29(1), 46–55. https://doi.org/10.18051/UnivMed.2010.v29.46-55
Review Article


Kusters JG, Van Vliet AHM, Kuipers EJ. Pathogenesis of Helicobacter pylori infections. Clin Microbiol Rev 2006;19:449-90.

Megraud F, Lehours P. Helicobacter pylori detection and antimicrobial susceptibility testing. Clin Microbiol Rev 2007;20:280-32.

NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in peptic ulcer disease. JAMA 1994;272:65-9.

Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001;345:784-9.

Tehuteru ES. Management of Helicobacter pylori infection in children. Univ Med 2004;23:110-4.

Malfertheiner P, Peitz U. The interplay between Helicobacter pylori, gastro-oesophageal reflux disease, and intestinal metaplasia. Gut 2005;54:13-20.

Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med 2002;347:1175-86.

Ottemann KM, Lowenthal AC. Helicobacter pylori uses motility for initial colonization and to attain robust infection. Infect Immun 2002;70: 1984-90.

Schreiber S, Konradt M, Groll C, Scheid P, Hanauer G, Werling HO, et al. The spatial orientation of Helicobacter pylori in the gastric mucosa. Proc Natl Acad Sci 2004;101:5024-9.

Petersen AM, Krogfelt KA. Helicobacter pylori: an invading microorganism? A review. FEMAS Immunol Med Microbiol 2003;36:117-26.

Peek RM, Crabtree JE. Helicobacter pylori and gastric neoplasia. J Pathol 2006;208:233-48.

Rupnow MF, Shachter RD, Owens DK, Parsonet JA. A dynamic transmission model for predicting trends in Helicobacter pylori and associated diseases in the United States. Emerg Infect Dis 2000;6:228-37.

Dunn BE, Cohen H, Blaser MJ. Helicobacter pylori. Clin Microbiol Rev 1997;10:720-61.

Heep M, Scheibl A, Degrell A, Lehn M. Transport and storage of fresh and frozen gastric biopsy specimens for optimal recovery of Helicobacter pylori. J Clin Microbiol 1999;37:3764-6.

Frenck RW Jr, Fathy HM, Sherif M, Mohran Z, El Mohammedy, Francis W, et al. Sensitivity and specificity of various tests for the diagnosis of Helicobacter pylori in Egyptian children. Pediatrics 2006;118:el1195-202.

Matsuda M, Noda Y, Takemori Y. Utility and limitations of a method for detecting Helicobacter pylori-specific antigens in the stool. J Gastroenterol 2003;38:222-8.

Richter JE. Effect of Helicobacter pylori eradication on the treatment of gastro-oesophageal reflux disease. Gut 2004;53:310-1.

Axon ATR. Personal view: to treat or not to treat? Helicobacter pylori and gastro-oesophageal reflux disease – an alternative hypothesis. Aliment Pharmacol Ther 2004;19:253-61.

Ragunath A, Hungin APS, Wooff D, Childs S. Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease: systematic review. Br Med J 2003;326:737-9.

Loffeld RJLF, Werdmuller BFM, Kuster JG, Perez GL, Blaser MJ, Kuipers EJ. Colonization with cagA-positive Helicobacter pylori strains inversely associated with reflux oesophagitis and Barret’s oesophagus. Digestion 2000;62:95-9.

Nakajima S, Hattori T. Active and inactive gastroeophageal reflux disease related to Helicobacter pylori therapy. Helicobacter 2003; 8:279-93.

Koike T, Ohara S, Sekine H, Iijima K, Abe Y, Kato K, et al. Helicobacter pylori prevents erosive reflux oesophagitis by by decreasing gastric acid secretion. Gut 2001;49:330-4.

Richter JE. Helicobacter pylori: the bug is not all bad. Gut 2001;49:319-21.

Haruma K, Hamada H, Mihara M, Kamada T, Yoshihara M, Sumi K, et al. Negative association between Helicobacter pylori infection and reflux esophagitis in older patients: case-control study in Japan. Helicobacter 2000;5:24-9.